MLchartDataset catalogue

methoxyamine

Term · Oncology and biomedicine · MLC-T-ONC-015130

An orally bioavailable small molecule inhibitor with potential adjuvant activity. Methoxyamine covalently binds to apurinic/apyrimidinic (AP) DNA damage sites and inhibits base excision repair (BER), which may result in an increase in DNA strand breaks and apoptosis. This agent may potentiate the anti-tumor activity of alkylating agents.

Table 1. Record
IdentifierMLC-T-ONC-015130
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015130",
  "term": "methoxyamine",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable small molecule inhibitor with potential adjuvant activity. Methoxyamine covalently binds to apurinic/apyrimidinic (AP) DNA damage sites and inhibits base excision repair (BER), which may result in an increase in DNA strand breaks and apoptosis. This agent may potentiate the anti-tumor activity of alkylating agents.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/methoxyamine/"
}

Record 10,943 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.